KMT2A PTDs, most frequently found in exons 2 to 9, occur in approximately 10% of myelodysplastic syndrome/acute myeloid leukemia (MDS/AML) cases and are linked to disease progression and relapse [11, 24]. The gene discussed is KMT2A; the disease is acute myeloid leukemia.